{"id":61829,"date":"2025-09-05T22:02:07","date_gmt":"2025-09-05T20:02:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/"},"modified":"2025-09-05T22:02:07","modified_gmt":"2025-09-05T20:02:07","slug":"ronovo-surgical-closes-series-d-financing","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/","title":{"rendered":"Ronovo Surgical Closes Series D Financing"},"content":{"rendered":"
\n

\nCompany advances commercialization in China through Targeted Collaboration Agreement with Johnson & Johnson<\/p>\n

SHANGHAI–(BUSINESS WIRE)–#artificialintelligence<\/a>—Ronovo Surgical<\/i>, a global innovator in next-generation surgical robotics, announced today the successful closing of its Series D financing, led by Johnson & Johnson\u2019s corporate venture capital organization, JJDC, and participation from Lilly Asia Ventures, INCE Capital and Granite Asia, with a total investment of USD 67 million.<\/p>\n

\nThis is Ronovo\u2019s second major funding round in 2025, following its Series C round led by Granite Asia earlier this year. With over USD 100 million raised this year alone, Ronovo continues to gain strong investor support for its vision to transform minimally invasive surgery around the world.<\/p>\n

\nIn addition to the Series D closing, Ronovo Surgical signed a targeted collaboration agreement with Johnson & Johnson Medical (Shanghai) Ltd. aimed at expanding surgical technology choice and access in China. The collaboration will offer hospitals in portions of the China market the advantages of Carina\u2122, Ronovo\u2019s flagship modular robotic surgery platform, alongside complementary Johnson & Johnson MedTech surgical technologies.<\/p>\n

\nCarina\u2122 received regulatory approval from China\u2019s National Medical Products Administration (NMPA) in March 2025, becoming the first modular surgical robotic system in the country to obtain a first-time filing covering four major specialties: General Surgery, Gynecology, Urology, and Thoracic Surgery. With its configurable modular architecture, Carina\u2122 addresses the flexibility, adaptability and affordability challenges posed by legacy robotic surgical systems.<\/p>\n

\nIn parallel, Ronovo has initiated global expansion, with submissions underway in Europe and South America. The platform has already received enthusiastic feedback from international key opinion leaders, validating Carina\u2019s differentiated value proposition and its ability to meet significant unmet needs across healthcare systems.<\/p>\n

\nDr. John Ma, Founder, Chairman, and CEO of Ronovo Surgical, commented:<\/p>\n

\n\u201cWe are grateful for the successful closing of our Series D round led by JJDC. Carina<\/i>\u2122\u2014flexible, adaptable, and affordable\u2014embodies our commitment to democratizing access to surgical robotics on a global scale. We\u2019re excited about the strategic collaboration with Johnson & Johnson MedTech, which will further accelerate our commercial momentum in China while laying the foundation for international growth.\u201d<\/i><\/p>\n

Contacts<\/b> <\/p>\n

\nZiHan Lin
\n
zlin@ronovo.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Company advances commercialization in China through Targeted Collaboration Agreement with Johnson & Johnson SHANGHAI–(BUSINESS WIRE)–#artificialintelligence—Ronovo Surgical, a global innovator in next-generation surgical robotics, announced today the successful closing of its Series D financing, led by Johnson & Johnson\u2019s corporate venture capital organization, JJDC, and participation from Lilly Asia Ventures, INCE Capital and Granite Asia, with … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61829","6":"format-standard","7":"category-industry"},"yoast_head":"\nRonovo Surgical Closes Series D Financing - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ronovo Surgical Closes Series D Financing - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Company advances commercialization in China through Targeted Collaboration Agreement with Johnson & Johnson SHANGHAI–(BUSINESS WIRE)–#artificialintelligence—Ronovo Surgical, a global innovator in next-generation surgical robotics, announced today the successful closing of its Series D financing, led by Johnson & Johnson\u2019s corporate venture capital organization, JJDC, and participation from Lilly Asia Ventures, INCE Capital and Granite Asia, with ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-05T20:02:07+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ronovo-surgical-closes-series-d-financing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ronovo-surgical-closes-series-d-financing\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Ronovo Surgical Closes Series D Financing\",\"datePublished\":\"2025-09-05T20:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ronovo-surgical-closes-series-d-financing\\\/\"},\"wordCount\":360,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ronovo-surgical-closes-series-d-financing\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ronovo-surgical-closes-series-d-financing\\\/\",\"name\":\"Ronovo Surgical Closes Series D Financing - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2025-09-05T20:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ronovo-surgical-closes-series-d-financing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ronovo-surgical-closes-series-d-financing\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ronovo-surgical-closes-series-d-financing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ronovo Surgical Closes Series D Financing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ronovo Surgical Closes Series D Financing - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/","og_locale":"en_US","og_type":"article","og_title":"Ronovo Surgical Closes Series D Financing - Pharma Trend","og_description":"Company advances commercialization in China through Targeted Collaboration Agreement with Johnson & Johnson SHANGHAI–(BUSINESS WIRE)–#artificialintelligence—Ronovo Surgical, a global innovator in next-generation surgical robotics, announced today the successful closing of its Series D financing, led by Johnson & Johnson\u2019s corporate venture capital organization, JJDC, and participation from Lilly Asia Ventures, INCE Capital and Granite Asia, with ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/","og_site_name":"Pharma Trend","article_published_time":"2025-09-05T20:02:07+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Ronovo Surgical Closes Series D Financing","datePublished":"2025-09-05T20:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/"},"wordCount":360,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/","url":"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/","name":"Ronovo Surgical Closes Series D Financing - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2025-09-05T20:02:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ronovo-surgical-closes-series-d-financing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ronovo Surgical Closes Series D Financing"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61829"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61829\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}